Improving care for advanced Parkinson’s patients through a dosing device, AI and real time monitoring
| Reference number | |
| Coordinator | Sensidose Aktiebolag |
| Funding from Vinnova | SEK 500 000 |
| Project duration | February 2019 - June 2019 |
| Status | Completed |
Important results from the project
The aim of the project was to do a a step 2 application to Horizon2020. The project´s goal was to develop a system for continuous, passive (non-patient demanding) objective evaluation of symptoms of Parkinson´s disease and to provide control instruments to the treating doctor / patient.
Expected long term effects
An application was written and submitted on time. Application received a total score: 13.28 (Threshold: 13) but was not awarded any funds. A so-called. "Seal of Excellence was obtained".
Approach and implementation
In the writing of the application, a consultant was used and all parties involved in the project participated. We note that further strengthening of the application must be made primarily within business strategic explanation and commercialization of the product.